These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Are there more than antibodies to the thyroid-stimulating hormone receptor that meet the eye in Graves' disease? Drexhage HA Endocrinology; 2006 Jan; 147(1):9-12. PubMed ID: 16365140 [No Abstract] [Full Text] [Related]
33. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459 [TBL] [Abstract][Full Text] [Related]
34. Effect of radioiodine therapy on the presence of autoantibodies against human thyroid and eye muscle fractions. Molnár I; Balázs C J Endocrinol Invest; 2000 Jan; 23(1):63-4. PubMed ID: 10698054 [No Abstract] [Full Text] [Related]
35. Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease. Aust G; Lehmann I; Heberling HJ Exp Clin Endocrinol Diabetes; 1996; 104(1):50-8. PubMed ID: 8750571 [TBL] [Abstract][Full Text] [Related]
36. [The incidence of the pituitary autoantibodies in Graves' disease]. Gut P; Kosowicz J; Ziemnicka K; Baczyk M; Sawicka J; Czarnywojtek A; Sowiński J Endokrynol Pol; 2007; 58(3):195-200. PubMed ID: 17940984 [TBL] [Abstract][Full Text] [Related]
37. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease. Ross PV; Koenig RJ; Arscott P; Ludgate M; Waier M; Nelson CC; Kaplan MM; Baker JR J Clin Endocrinol Metab; 1993 Aug; 77(2):433-8. PubMed ID: 8345048 [TBL] [Abstract][Full Text] [Related]
38. Thyrotropin binding inhibiting antibody (TBIAb) in Graves' disease. Cho WY; Choi HH; Chun HJ; Ahn IM Korean J Intern Med; 1988 Jan; 3(1):45-51. PubMed ID: 2908684 [TBL] [Abstract][Full Text] [Related]
40. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism. Kubota S; Gunji K; Ackrell BA; Cochran B; Stolarski C; Wengrowicz S; Kennerdell JS; Hiromatsu Y; Wall J J Clin Endocrinol Metab; 1998 Feb; 83(2):443-7. PubMed ID: 9467555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]